Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age
Authors:
- M GosneyMGM Gosney
- A HaycoxAHA Haycox
- M ReganMRM Regan
Open Access
- 1 August 2003
- journal article
- clinical trial
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 7 (24)
Abstract
Health Technology Assessment Volume: 7, Issue: 24, Published in September 2003Keywords
Funding Information
- Health Technology Assessment Programme (97/20/06)
This publication has 50 references indexed in Scilit:
- Influenza-Associated Morbidity and Mortality in Young and Middle-Aged WomenJAMA, 1999
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of internal medicine (1960), 1998
- A Study of the Impact of Influenza on the Functional Status of Frail Older PeopleArchives of internal medicine (1960), 1998
- Reactions Following Administration of Influenza Vaccine Alone or With Pneumococcal Vaccine to the ElderlyArchives of internal medicine (1960), 1996
- Clinical Effectiveness of Influenza Vaccination in ManitobaJAMA, 1993
- The Impact and Cost of Influenza in the ElderlyArchives of internal medicine (1960), 1993
- Frequency of Adverse Reactions to Influenza Vaccine in the ElderlyJAMA, 1990
- Simultaneous Administration of Influenza and Pneumococcal VaccinesJAMA, 1982
- Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deathsJAMA, 1980
- Observations on Excess Mortality Associated with Epidemic InfluenzaJAMA, 1961